サマリー

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Drug Discovery Service are specifically designed to minimize the costs and timelines of drug discovery.Skipping the tedious labeling and optimization steps required by other drug screening technologies, the label-free method eliminates the long time, higher cost and false positive results required by traditional detection methods.

Market Analysis and Insights: Global Label-Free Drug Discovery Market
The global Label-Free Drug Discovery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Label-Free Drug Discovery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Label-Free Drug Discovery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Label-Free Drug Discovery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Label-Free Drug Discovery market.

Global Label-Free Drug Discovery Scope and Market Size
Label-Free Drug Discovery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Label-Free Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cellular Dielectric Spectroscopy
Bio-layer Interferometry
Surface Plasmon Resonance
Optical Waveguide Grating Technology

Segment by Application
Pharmaceutical Companies
Research Laboratories
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
GE Healthcare
Corning
Albany Molecular Research, Inc (AMRI)
Charles River Laboratories
Evotec
Jubilant Biosys
WuXi AppTec
Agilent
SAMDI Tech

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Label-Free Drug Discovery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cellular Dielectric Spectroscopy
1.2.3 Bio-layer Interferometry
1.2.4 Surface Plasmon Resonance
1.2.5 Optical Waveguide Grating Technology
1.3 Market by Application
1.3.1 Global Label-Free Drug Discovery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Companies
1.3.3 Research Laboratories
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Label-Free Drug Discovery Market Perspective (2016-2027)
2.2 Label-Free Drug Discovery Growth Trends by Regions
2.2.1 Label-Free Drug Discovery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Label-Free Drug Discovery Historic Market Share by Regions (2016-2021)
2.2.3 Label-Free Drug Discovery Forecasted Market Size by Regions (2022-2027)
2.3 Label-Free Drug Discovery Industry Dynamic
2.3.1 Label-Free Drug Discovery Market Trends
2.3.2 Label-Free Drug Discovery Market Drivers
2.3.3 Label-Free Drug Discovery Market Challenges
2.3.4 Label-Free Drug Discovery Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Label-Free Drug Discovery Players by Revenue
3.1.1 Global Top Label-Free Drug Discovery Players by Revenue (2016-2021)
3.1.2 Global Label-Free Drug Discovery Revenue Market Share by Players (2016-2021)
3.2 Global Label-Free Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Label-Free Drug Discovery Revenue
3.4 Global Label-Free Drug Discovery Market Concentration Ratio
3.4.1 Global Label-Free Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Label-Free Drug Discovery Revenue in 2020
3.5 Label-Free Drug Discovery Key Players Head office and Area Served
3.6 Key Players Label-Free Drug Discovery Product Solution and Service
3.7 Date of Enter into Label-Free Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Label-Free Drug Discovery Breakdown Data by Type
4.1 Global Label-Free Drug Discovery Historic Market Size by Type (2016-2021)
4.2 Global Label-Free Drug Discovery Forecasted Market Size by Type (2022-2027)

5 Label-Free Drug Discovery Breakdown Data by Application
5.1 Global Label-Free Drug Discovery Historic Market Size by Application (2016-2021)
5.2 Global Label-Free Drug Discovery Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Label-Free Drug Discovery Market Size (2016-2027)
6.2 North America Label-Free Drug Discovery Market Size by Type
6.2.1 North America Label-Free Drug Discovery Market Size by Type (2016-2021)
6.2.2 North America Label-Free Drug Discovery Market Size by Type (2022-2027)
6.2.3 North America Label-Free Drug Discovery Market Size by Type (2016-2027)
6.3 North America Label-Free Drug Discovery Market Size by Application
6.3.1 North America Label-Free Drug Discovery Market Size by Application (2016-2021)
6.3.2 North America Label-Free Drug Discovery Market Size by Application (2022-2027)
6.3.3 North America Label-Free Drug Discovery Market Size by Application (2016-2027)
6.4 North America Label-Free Drug Discovery Market Size by Country
6.4.1 North America Label-Free Drug Discovery Market Size by Country (2016-2021)
6.4.2 North America Label-Free Drug Discovery Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Label-Free Drug Discovery Market Size (2016-2027)
7.2 Europe Label-Free Drug Discovery Market Size by Type
7.2.1 Europe Label-Free Drug Discovery Market Size by Type (2016-2021)
7.2.2 Europe Label-Free Drug Discovery Market Size by Type (2022-2027)
7.2.3 Europe Label-Free Drug Discovery Market Size by Type (2016-2027)
7.3 Europe Label-Free Drug Discovery Market Size by Application
7.3.1 Europe Label-Free Drug Discovery Market Size by Application (2016-2021)
7.3.2 Europe Label-Free Drug Discovery Market Size by Application (2022-2027)
7.3.3 Europe Label-Free Drug Discovery Market Size by Application (2016-2027)
7.4 Europe Label-Free Drug Discovery Market Size by Country
7.4.1 Europe Label-Free Drug Discovery Market Size by Country (2016-2021)
7.4.2 Europe Label-Free Drug Discovery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Label-Free Drug Discovery Market Size (2016-2027)
8.2 Asia-Pacific Label-Free Drug Discovery Market Size by Type
8.2.1 Asia-Pacific Label-Free Drug Discovery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Label-Free Drug Discovery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Label-Free Drug Discovery Market Size by Type (2016-2027)
8.3 Asia-Pacific Label-Free Drug Discovery Market Size by Application
8.3.1 Asia-Pacific Label-Free Drug Discovery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Label-Free Drug Discovery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Label-Free Drug Discovery Market Size by Application (2016-2027)
8.4 Asia-Pacific Label-Free Drug Discovery Market Size by Region
8.4.1 Asia-Pacific Label-Free Drug Discovery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Label-Free Drug Discovery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Label-Free Drug Discovery Market Size (2016-2027)
9.2 Latin America Label-Free Drug Discovery Market Size by Type
9.2.1 Latin America Label-Free Drug Discovery Market Size by Type (2016-2021)
9.2.2 Latin America Label-Free Drug Discovery Market Size by Type (2022-2027)
9.2.3 Latin America Label-Free Drug Discovery Market Size by Type (2016-2027)
9.3 Latin America Label-Free Drug Discovery Market Size by Application
9.3.1 Latin America Label-Free Drug Discovery Market Size by Application (2016-2021)
9.3.2 Latin America Label-Free Drug Discovery Market Size by Application (2022-2027)
9.3.3 Latin America Label-Free Drug Discovery Market Size by Application (2016-2027)
9.4 Latin America Label-Free Drug Discovery Market Size by Country
9.4.1 Latin America Label-Free Drug Discovery Market Size by Country (2016-2021)
9.4.2 Latin America Label-Free Drug Discovery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Label-Free Drug Discovery Market Size (2016-2027)
10.2 Middle East & Africa Label-Free Drug Discovery Market Size by Type
10.2.1 Middle East & Africa Label-Free Drug Discovery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Label-Free Drug Discovery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Label-Free Drug Discovery Market Size by Type (2016-2027)
10.3 Middle East & Africa Label-Free Drug Discovery Market Size by Application
10.3.1 Middle East & Africa Label-Free Drug Discovery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Label-Free Drug Discovery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Label-Free Drug Discovery Market Size by Application (2016-2027)
10.4 Middle East & Africa Label-Free Drug Discovery Market Size by Country
10.4.1 Middle East & Africa Label-Free Drug Discovery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Label-Free Drug Discovery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Label-Free Drug Discovery Introduction
11.1.4 Thermo Fisher Scientific Revenue in Label-Free Drug Discovery Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Label-Free Drug Discovery Introduction
11.2.4 GE Healthcare Revenue in Label-Free Drug Discovery Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Corning
11.3.1 Corning Company Details
11.3.2 Corning Business Overview
11.3.3 Corning Label-Free Drug Discovery Introduction
11.3.4 Corning Revenue in Label-Free Drug Discovery Business (2016-2021)
11.3.5 Corning Recent Development
11.4 Albany Molecular Research, Inc (AMRI)
11.4.1 Albany Molecular Research, Inc (AMRI) Company Details
11.4.2 Albany Molecular Research, Inc (AMRI) Business Overview
11.4.3 Albany Molecular Research, Inc (AMRI) Label-Free Drug Discovery Introduction
11.4.4 Albany Molecular Research, Inc (AMRI) Revenue in Label-Free Drug Discovery Business (2016-2021)
11.4.5 Albany Molecular Research, Inc (AMRI) Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Label-Free Drug Discovery Introduction
11.5.4 Charles River Laboratories Revenue in Label-Free Drug Discovery Business (2016-2021)
11.5.5 Charles River Laboratories Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec Label-Free Drug Discovery Introduction
11.6.4 Evotec Revenue in Label-Free Drug Discovery Business (2016-2021)
11.6.5 Evotec Recent Development
11.7 Jubilant Biosys
11.7.1 Jubilant Biosys Company Details
11.7.2 Jubilant Biosys Business Overview
11.7.3 Jubilant Biosys Label-Free Drug Discovery Introduction
11.7.4 Jubilant Biosys Revenue in Label-Free Drug Discovery Business (2016-2021)
11.7.5 Jubilant Biosys Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Details
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec Label-Free Drug Discovery Introduction
11.8.4 WuXi AppTec Revenue in Label-Free Drug Discovery Business (2016-2021)
11.8.5 WuXi AppTec Recent Development
11.9 Agilent
11.9.1 Agilent Company Details
11.9.2 Agilent Business Overview
11.9.3 Agilent Label-Free Drug Discovery Introduction
11.9.4 Agilent Revenue in Label-Free Drug Discovery Business (2016-2021)
11.9.5 Agilent Recent Development
11.10 SAMDI Tech
11.10.1 SAMDI Tech Company Details
11.10.2 SAMDI Tech Business Overview
11.10.3 SAMDI Tech Label-Free Drug Discovery Introduction
11.10.4 SAMDI Tech Revenue in Label-Free Drug Discovery Business (2016-2021)
11.10.5 SAMDI Tech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details